Mitchell Blutt, the founder and CEO of Consonance Capital in New York City, has been part of the medical community for more than 30 years. Since 1987, Mitchell Blutt has been a professor at Cornell University's Weill Cornell Medicine. Weill Cornell Medicine has a variety of graduate doctoral programs, including an MD-PhD program. Offered in partnership with Rockefeller University and the Sloan Kettering Institute, the MD-PhD program trains physician-scientists who have a clear understanding of both clinical medicine and laboratory research. The schools typically offer 18 positions each year, all of which are fully funded by grants, in large part from the National Institutes of Health and its Medical Scientist Training Program. Students have access to nearly 300 faculty members, ensuring exposure to a wide range of research interests. Since the program began in 1972, 300 students have graduated. Graduates receive an MD from Weill Cornell and a PhD from any one of the three partner institutions in the project.
0 Comments
Leave a Reply. |
AuthorMaintaining an assortment of professional affiliations, Mitchell Blutt, MD, serves as founder and chief executive officer of Manhattan-based healthcare investment firm Consonance Capital. ArchivesCategories |